Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Molecular Templates, Inc. | Director, 10%+ Owner | Common Stock | 406K | $955K | $2.35 | Apr 2, 2024 | By Sante Health Ventures I, L.P. |
Molecular Templates, Inc. | Director, 10%+ Owner | Pre-Funded Warrants (Right to Buy) | 402K | $944K | $2.35 | Apr 2, 2024 | By SHV MTEM SPV, LLC |
Molecular Templates, Inc. | Director, 10%+ Owner | Common Stock | 175K | $411K | $2.35 | Apr 2, 2024 | By SHV MTEM SPV, LLC |
Molecular Templates, Inc. | Director, 10%+ Owner | Common Stock | 57.6K | $135K | $2.35 | Apr 2, 2024 | By Sante Health Ventures I Annex Fund, L.P. |
Molecular Templates, Inc. | Director, 10%+ Owner | Common Stock | 14.8K | $34.8K | $2.35 | Apr 2, 2024 | By SHVMS, LLC |
Molecular Templates, Inc. | Director, 10%+ Owner | Common Stock | 3.33K | $7.83K | $2.35 | Apr 2, 2024 | By SHV Management Services, L.P. |
LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | Dec 12, 2024 | By Sante Health Ventures II, LP |
LUMOS PHARMA, INC. | Director | Common Stock | 0 | $0 | $1.89 | Dec 12, 2024 | Direct |
Molecular Templates, Inc. | Director, 10%+ Owner | Warrants (Right to Buy) | 1.15M | Apr 2, 2024 | By SHV MTEM SPV, LLC | ||
Molecular Templates, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 1K | Sep 27, 2024 | Direct | ||
LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 0 | Dec 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
(LUMO) | LUMOS PHARMA, INC. | Dec 12, 2024 | 7 | $0 | 4 | Dec 13, 2024 | Director |
MTEM | Molecular Templates, Inc. | Sep 27, 2024 | 1 | $0 | 4 | Sep 30, 2024 | Director, 10%+ Owner |
(LUMO) | LUMOS PHARMA, INC. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
MTEM | Molecular Templates, Inc. | Apr 2, 2024 | 3 | $1.5M | 4 | Apr 4, 2024 | Director, 10%+ Owner |
MTEM | Molecular Templates, Inc. | Oct 27, 2023 | 1 | $0 | 4 | Oct 31, 2023 | Director, 10%+ Owner |
LUMO | LUMOS PHARMA, INC. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
MTEM | Molecular Templates, Inc. | Jun 13, 2022 | 3 | $198K | 4 | Jun 21, 2022 | Director, 10%+ Owner |
MTEM | Molecular Templates, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
LUMO | LUMOS PHARMA, INC. | May 5, 2022 | 1 | $0 | 4 | May 9, 2022 | Director |
LUMO | LUMOS PHARMA, INC. | Sep 8, 2021 | 1 | $112K | 4 | Sep 10, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Sep 2, 2021 | 3 | $274K | 4 | Sep 7, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 30, 2021 | 3 | $205K | 4 | Sep 1, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 25, 2021 | 3 | $262K | 4 | Aug 27, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 20, 2021 | 3 | $776K | 4 | Aug 24, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 17, 2021 | 3 | $556K | 4 | Aug 19, 2021 | Director |
LUMO | LUMOS PHARMA, INC. | Aug 12, 2021 | 3 | $724K | 4 | Aug 16, 2021 | Director |
MTEM | Molecular Templates, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 4, 2021 | Director, 10%+ Owner |
LUMO | LUMOS PHARMA, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |